EcoDrugPlus

Melanocortin 1 Receptor

Ensembl ID : ENSORLG00000009400
Gene Symbol: MC1R
1 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSORLG00000013531
Gene Symbol: MC4R
1 Cross references
89 Possible Orthologues:

Melanoma Receptor Tyrosine-Protein Kinase

Ensembl ID : ENSORLG00000003577
Gene Symbol: LOC101169984
3 Cross references
215 Possible Orthologues:

Melatonin Receptor 1a A

Ensembl ID : ENSORLG00000008141
Gene Symbol: MTNR1AA
4 Cross references
186 Possible Orthologues:

Membrane Guanylyl Cyclase

Ensembl ID : ENSORLG00000020832
Gene Symbol: OLGC2
3 Cross references
191 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSORLG00000005790
Gene Symbol: MME
4 Cross references
231 Possible Orthologues:

Metabotropic Glutamate Receptor 4

Ensembl ID : ENSORLG00000013266
Gene Symbol: LOC101164479
3 Cross references
196 Possible Orthologues:

Metabotropic Glutamate Receptor 4

Ensembl ID : ENSORLG00000007238
Gene Symbol: LOC101157686
3 Cross references
207 Possible Orthologues:

Methionyl Aminopeptidase 2

Ensembl ID : ENSORLG00000016650
Gene Symbol: METAP2
4 Cross references
220 Possible Orthologues:

Microtubule-Associated Protein Tau A

Ensembl ID : ENSORLG00000012867
Gene Symbol: MAPTA
3 Cross references
205 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSORLG00000027138
Gene Symbol: MAPK1
4 Cross references
211 Possible Orthologues:

Mitogen-Activated Protein Kinase 10

Ensembl ID : ENSORLG00000006276
Gene Symbol: MAPK10
4 Cross references
88 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).